financetom
Business
financetom
/
Business
/
Braze Insider Sold Shares Worth $1,858,159, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Braze Insider Sold Shares Worth $1,858,159, According to a Recent SEC Filing
Dec 20, 2024 3:13 PM

05:56 PM EST, 12/20/2024 (MT Newswires) -- Susan Wiseman, General Counsel, on December 18, 2024, sold 41,210 shares in Braze (BRZE) for $1,858,159. Following the Form 4 filing with the SEC, Wiseman has control over a total of 199,520 shares of the company, with 199,520 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1676238/000167623824000218/xslF345X05/wk-form4_1734735228.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Integral Ad Science to Be Taken Private by Novacap in $1.9 Billion Deal; Shares Surge
Integral Ad Science to Be Taken Private by Novacap in $1.9 Billion Deal; Shares Surge
Sep 24, 2025
10:03 AM EDT, 09/24/2025 (MT Newswires) -- Shares of Integral Ad Science ( IAS ) soared on Wednesday after the digital ad verification company agreed to be acquired and taken private by Novacap in an all-cash deal worth $1.9 billion. Shareholders of media measurement and optimization platform Integral Ad Science ( IAS ) will receive $10.30 per share from the...
Form 8.3 - SPECTRIS PLC
Form 8.3 - SPECTRIS PLC
Sep 24, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short
Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short
Sep 24, 2025
Acadia Pharmaceuticals Inc. ( ACAD ) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients with hyperphagia in Prader-Willi syndrome (PWS). PWS is a rare genetic disorder characterized by muscle weakness and feeding difficulties in infancy, followed by an insatiable hunger and tendency toward severe obesity...
California Resources Plans Private Offering of $400 Million Notes
California Resources Plans Private Offering of $400 Million Notes
Sep 24, 2025
10:03 AM EDT, 09/24/2025 (MT Newswires) -- California Resources ( CRC ) said Wednesday it intends to sell $400 million of senior unsecured notes due 2034 in a private offering. The company said it plans to use the net proceeds, along with cash on hand and borrowings, to help repay Berry's (BRY) existing debt in connection with their pending merger...
Copyright 2023-2026 - www.financetom.com All Rights Reserved